Metraipolis › archive › dc_cd00eda3e806
Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD study — Europe PMC PMID:41449381
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41449381
- DOI
- 10.1186/s12879-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:06:41.847Z
- SHA-256 of the archived text
7034b35100c33e5f56125bcffd9faec2ab28621936e41892b7bab4f375e53e21- Stable URL of this page
https://metraipolis.com/documento/dc_cd00eda3e806
How to cite
Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD study — Europe PMC PMID:41449381 — Europe PMC (en), https://europepmc.org/article/MED/41449381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd00eda3e806 (Metraipolis archive dc_cd00eda3e806, sha256 7034b35100c33e5f56125bcffd9faec2ab28621936e41892b7bab4f375e53e21)
BibTeX
@misc{dccd00eda3e806,
title = {Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD study — Europe PMC PMID:41449381},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41449381},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd00eda3e806; sha256 7034b35100c33e5f56125bcffd9faec2ab28621936e41892b7bab4f375e53e21},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41449381. Agents can read the archived copy with the MCP tool read_document.